Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT04066647

Detection of miRNAs in HPA Axis Function in Healthy Subjects

Sponsor: Cedars-Sinai Medical Center

Conditions Dexamethasone Effect on miRNA Profile in Healthy Humans

Updated 8 times since 2019 Last updated: Jul 15, 2020 Started: May 9, 2019 Primary completion: Jul 24, 2019 Completion: Jul 24, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Interim analysis shows results opposite of hypothesized.

Other terminated trials from Cedars-Sinai Medical Center

See all terminations from Cedars-Sinai Medical Center

This PHASE1/PHASE2 trial investigates Dexamethasone Effect on miRNA Profile in Healthy Humans and is currently terminated or withdrawn. Cedars-Sinai Medical Center leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE1_PHASE2
Jan 2021 — Dec 2022 [monthly]

Terminated PHASE1_PHASE2

▶ Show 3 earlier versions

Aug 2020 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2
Oct 2019 — Aug 2020 [monthly]

Terminated PHASE1_PHASE2

Status: Recruiting → Terminated
Sep 2019 — Oct 2019 [monthly]

Recruiting PHASE1_PHASE2

First recorded

May 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cedars-Sinai Medical Center

Data source: Cedars-Sinai Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States